Your browser doesn't support javascript.
loading
Gastric Non-Hodgkin Lymphoma in a Helicobacter pylori-Infected Patient.
Alenzi, Maram; Alabdul Razzak, Iyiad; Evanchuk, Darren; Kondratiev, Svetlana; Mahmood, Syed Kashif; Tandon, Manish.
Afiliação
  • Alenzi M; Division of Gastroenterology, St. Elizabeth's Medical Center, Boston University School of Medicine, Boston, MA.
  • Alabdul Razzak I; Division of Gastroenterology, St. Elizabeth's Medical Center, Boston University School of Medicine, Boston, MA.
  • Evanchuk D; Division of Hematology and Oncology, St. Elizabeth's Medical Center, Boston University School of Medicine, Boston, MA.
  • Kondratiev S; Division of Histopathology, St. Elizabeth's Medical Center, Boston University School of Medicine, Boston, MA.
  • Mahmood SK; Division of Gastroenterology, St. Elizabeth's Medical Center, Boston University School of Medicine, Boston, MA.
  • Tandon M; Division of Gastroenterology, St. Elizabeth's Medical Center, Boston University School of Medicine, Boston, MA.
ACG Case Rep J ; 11(6): e01373, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38903454
ABSTRACT
Primary gastric diffuse large B-cell lymphoma (PG-DLBCL) is a rare gastric malignant neoplasm. While the association between Heliobacter pylori infection and gastric mucosa-assisted lymphoid tissue lymphoma is well established, data supporting its association with DLBCL are less robust. Here we present a rare case of PG-DLBCL diagnosed with H. pylori. An 82-year-old man presented to clinic with complaints of worsening epigastric pain. He underwent an endoscopy which revealed 1 large nonbleeding gastric ulcer. Histopathological and immunohistochemical analysis confirmed PG-DLBCL. He was started on H. pylori eradication (HPE) and subsequently completed 6 cycles of R-mini-CHOP chemotherapy. Since then, the patient maintained clinical and radiological remission for more than a year without recurrence. PG-DLBCL is an aggressive Non-hodgkin lymphoma (NHL) that usually presents late. It has been shown that HPE without chemotherapy in DLBCL codiagnosed with H. pylori is not an effective strategy. Thus, the standard of care for patients would be HPE and chemotherapy as in our patient. More research is needed to better understand association between H. pylori and DLBCL.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article